Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anne E. Daigle
Observed names:
A Daigle,
A E Daigle,
A. E. Daigle,
ANNE DAIGLE,
Anne Daigle
Institutions:
Naval Medical Center San Diego,
Graduate Hospital,
University of Pennsylvania
Observed institutions:
University of Southern California,
Naval Medical Center San Diego,
University of Minnesota,
Salk Institute for Biological Studies,
University of Michigan,
Graduate Hospital,
C. S. Mott Children's Hospital,
University of Pennsylvania
show all 8
OpenAlex ID:
A5077964014
Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the childrens cancer study group)
1989
·
Leslie L. Robison
, Jonathan D. Buckley
, et al.
·
Cancer
·
209
PDF
Control Selection Using Random Digit Dialing for Cases of Childhood Cancer1
1984
·
LESLIE L. ROBISON
, ANNE DAIGLE
·
American Journal of Epidemiology
·
101
Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells
1994
·
R. J. Trauger
, F. Ferre
, et al.
·
The Journal of Infectious Diseases
·
75
Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up
1996
·
Alexandra M. Levine
, Susan Groshen
, et al.
·
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
·
63
A case-control study of the etiology of Ewing's sarcoma.
1992
·
D M Winn
, F P Li
, et al.
·
PubMed
·
59
HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity: results of a double-blind, adjuvant-controlled, dose-ranging trial
1994
·
John L. Turner
, Richard J. Trauger
, et al.
·
AIDS
·
33
The effects of an HIV‐1 immunogen (Remune) on viral load, CD4 cell counts and HIV‐specific immunity in a double‐blind, randomized, adjuvant‐controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs
2001
·
JL Turner
, JR Kostman
, et al.
·
HIV Medicine
·
32
PDF
Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection
1997
·
Ronald B. Moss
, Richard J. Trauger
, et al.
·
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
·
30
Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia
1984
·
William G. Woods
, Anne E. Daigle
, et al.
·
The Journal of Pediatrics
·
27
Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.
1995
·
F Ferre
, R B Moss
, et al.
·
PubMed
·
22
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy
1996
·
Ronald B. Moss
, Francois Ferre
, et al.
·
Journal of Clinical Immunology
·
20
Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.
1995
·
R J Trauger
, A E Daigle
, et al.
·
PubMed
·
20
Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment
1993
·
Francois Ferre
, Ana L. Marchese
, et al.
·
AIDS
·
17
Inactivated HIV-1 Immunogen: impact on markers of disease progression.
1994
·
R B Moss
, F Ferré
, et al.
·
PubMed
·
11
HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression
1997
·
Ronald B. Moss
, Steven P. Richieri
, et al.
·
Journal of Biomedical Science
·
7
Quantification of RNA Targets Using the Polymerase Chain Reaction
1995
·
Francois Ferre
, Patrick Pezzoli
, et al.
·
Elsevier eBooks
·
5
Pentigetide nasal solution: a multicenter study evaluating efficacy and safety in patients with seasonal allergic rhinitis.
1991
·
H C Mansmann
, J Rosen
, et al.
·
PubMed
·
5
Combination Therapies Against HIV-1 Infection: Exploring the Concept of Combining Antiretroviral Drug Treatments with HIV-1 Immune-Based Therapies in Asymptomatic Individuals. . .
1996
·
Francois Ferre
, Ronald B. Moss
, et al.
·
AIDS Patient Care and STDs
·
3
Safety and Tolerability of Single Intravenous Doses of T Cell Modulatory Peptide (TCMP‐80) in Healthy Volunteers
1990
·
Michael A. Eldon
, Richard A. Smith
, et al.
·
The Journal of Clinical Pharmacology
Show more works
View as search
Works count:
20
Citation count:
739
H-index:
13
I10-index:
14
Year
Topic
Type